SAFETY OF ENALAPRIL IN INFANTS: DATA FROM THE PEDIATRIC HEART NETWORK INFANT WITH SINGLE VENTRICLE TRIAL

Background: Angiotension converting enzyme (ACE) inhibitor therapy has been shown to improve ventricular function and clinical outcomes in adult patients with heart failure. Despite the lack of safety and efficacy data, empiric use of ACE inhibitor therapy is common in infants and children with